Recent agents targeting HIF‐1α for cancer therapy
作者： Yaozhong Hu , Jing Liu , He Huang
DOI: 10.1002/JCB.24390
关键词:
摘要: … Binding of 4E-BP1 to eIF-4E inactivates the latter, inhibiting cap-dependent mRNA translation. Phosphorylation of 4E-BP1 … Resveratrol Resveratrol has been shown to be an effective …
sci-hub.se 
researchgate.net 参考文章(90)
Albena T. Dinkova-Kostova, Chemoprotection Against Cancer by Isothiocyanates: A Focus on the Animal Models and the Protective Mechanisms Topics in Current Chemistry. ,vol. 329, pp. 179- 201 ,(2012) , 10.1007/128_2012_337
Q C Yang, C X Yang, Y M Lv, B F Zeng, Y W Liu, Y Dong, Z M Jiang, Z M Shi, J Huang, Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. Journal of Experimental & Clinical Cancer Research. ,vol. 25, pp. 593- 599 ,(2006)
Michael I. Koukourakis, Alexandros Polychronidis, Sotirios Botaitis, Constantinos Simopoulos, Alexandra Giatromanolaki, Efthimios Sivridis, Sebach Perente, The effect of trastuzumab/docatexel combination on breast cancer angiogenesis: dichotomus effect predictable by the HIFI alpha/VEGF pre-treatment status? Anticancer Research. ,vol. 23, pp. 1673- 1680 ,(2003)
Hassan M.E Azzazy, W.Edward Highsmith, Phage display technology: clinical applications and recent innovations. Clinical Biochemistry. ,vol. 35, pp. 425- 445 ,(2002) , 10.1016/S0009-9120(02)00343-0
G.L. Wang, G.L. Semenza, Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. Journal of Biological Chemistry. ,vol. 268, pp. 21513- 21518 ,(1993) , 10.1016/S0021-9258(20)80571-7
Gillian Paine-Murrieta, Sarah Welsh, Lynn Kirkpatrick, Ryan Williams, Garth Powis, Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α Molecular Cancer Therapeutics. ,vol. 3, pp. 233- 244 ,(2004)
Benoit Vlaminck, Sebastien Toffoli, Benjamin Ghislain, Catherine Demazy, Martine Raes, Carine Michiels, Dual effect of echinomycin on hypoxia‐inducible factor‐1 activity under normoxic and hypoxic conditions FEBS Journal. ,vol. 274, pp. 5533- 5542 ,(2007) , 10.1111/J.1742-4658.2007.06072.X
Claire S. Jacobs, Peter B. Dervan, Modifications at the C-terminus to improve pyrrole-imidazole polyamide activity in cell culture. Journal of Medicinal Chemistry. ,vol. 52, pp. 7380- 7388 ,(2009) , 10.1021/JM900256F
D. Ross Camidge, Qing Zhou, Daniel Gustafson, Sujatha Nallapareddy, Sami Diab, Stephen Leong, Karl Lewis, Lia Gore, Wells A. Messersmith, Anthony M. Treston, S. Gail Eckhardt, Carolyn Sidor, A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer. Investigational New Drugs. ,vol. 29, pp. 340- 346 ,(2011) , 10.1007/S10637-009-9383-9
Arjan J Groot, Peter Verheesen, Elike J Westerlaken, Eelke H Gort, Petra van der Groep, Niels Bovenschen, Elsken van der Wall, Paul J van Diest, Avi Shvarts, Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha Laboratory Investigation. ,vol. 86, pp. 345- 356 ,(2006) , 10.1038/LABINVEST.3700395